“The great hope of society is in individual character…”
~William Ellery Channing
This section focuses on articles related mainly to the finance society.
OUR MAIN READS
2018 EU-US Outlook: Where do we come from? What are we? Where are we going?
As the first quarter of the year is headed to the end and new challenges lay ahead for international financial markets, frame the actual situation is necessary to adapt to future changes. 2017 has been a record year both in terms of returns and volatility. Looking at historic data, seems obvious the past year representsContinue reading “2018 EU-US Outlook: Where do we come from? What are we? Where are we going?”
Everything happening in the Markets: Winners and Losers of 2016
Here’s a look at some of the best and worst performing assets in global financial markets as 2016 ends. Currencies British pounds are almost unanimously rated to be the worst performing currency in the year of 2016, which suffered significant devaluation due to the Brexit referendum on 23rd June, 2016. Overnight GBP plummeted, a priceContinue reading “Everything happening in the Markets: Winners and Losers of 2016”
On the Rollercoaster – Yearly Recap
The 2015 has been a very turbulent year for financial markets globally. Greece, the unpredictable oil rout and weak growth perspective in China repeatedly triggered waves of sell-offs during the last year. Here a closer look at the main characters or events that set the trends this year. S&P 500 Yearly Performance Oil The oilContinue reading “On the Rollercoaster – Yearly Recap”
About Us
The ESCP Finance Society is the oldest and largest student-run Association active in the finance field of ESCP Business School.
The mission of the ESCP Finance Society is to help ESCP students to break into the Finance Industry, organising dedicated networking events and providing useful materials to support the application and interview process.
Get In Touch
Must Read
- Pharmaceutical, Pfizer acquires California-based Arena
On the 13th of December 2021 Pfizer Inc, a US-based pharmaceutical company, announced a definitive agreement to buy Arena Pharmaceuticals Inc, a clinical stage company. The value of the deal amounts to $6.73bn, with an offer price of $100 per share. The board of directors of both companies have unanimously approved the transaction. Investment ConsiderationsContinue reading “Pharmaceutical, Pfizer acquires California-based Arena”
ESCP Finance Society 